Home
/
UTAH MEDICAL PRODUCTS INC
/
Financials
/
Quarterly
UTAH MEDICAL PRODUCTS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that UTAH MEDICAL PRODUCTS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$9.81M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$9.95M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$9.71M
May 15, 2025
Q3
2025
Sep 30, 2024
$10.01M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$10.40M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$11.34M
May 15, 2025
Q3
2024
Sep 30, 2023
$12.51M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$12.87M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$12.52M
May 10, 2024
Q3
2023
Sep 30, 2022
$12.96M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$13.43M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$12.32M
May 5, 2023
Q3
2022
Sep 30, 2021
$12.57M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$12.60M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$10.96M
May 11, 2022
Q3
2021
Sep 30, 2020
$10.48M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$8.79M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$10.90M
May 11, 2021
Q3
2020
Sep 30, 2019
$12.49M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$11.85M
Aug 7, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$10.97M
Aug 9, 2018
Q1
2018
Mar 31, 2018
$10.89M
May 9, 2018
Q3
2017
Sep 30, 2017
$10.13M
Nov 7, 2017
Q2
2018
Jun 30, 2017
$10.83M
Aug 9, 2018
Q1
2018
Mar 31, 2017
$10.26M
May 9, 2018
Q3
2017
Sep 30, 2016
$9.66M
Nov 7, 2017
Q2
2017
Jun 30, 2016
$10.49M
Aug 3, 2017
Q1
2017
Mar 31, 2016
$10.30M
May 5, 2017
Q3
2016
Sep 30, 2015
$9.95M
Nov 4, 2016
Q2
2016
Jun 30, 2015
$10.40M
Aug 8, 2016
Q1
2016
Mar 31, 2015
$10.23M
May 6, 2016
Q3
2015
Sep 30, 2014
$10.72M
Nov 6, 2015
Q2
2015
Jun 30, 2014
$10.49M
Aug 7, 2015
Q1
2015
Mar 31, 2014
$9.83M
May 6, 2015
Q3
2014
Sep 30, 2013
$10.03M
Nov 4, 2014
Q2
2014
Jun 30, 2013
$10.00M
Aug 8, 2014
Q1
2014
Mar 31, 2013
$10.37M
May 7, 2014
Q3
2013
Sep 30, 2012
$10.49M
Nov 6, 2013
Q2
2013
Jun 30, 2012
$10.03M
Aug 8, 2013
Q1
2013
Mar 31, 2012
$11.21M
May 8, 2013
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.61M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$3.20M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$3.15M
May 15, 2025
Q3
2025
Sep 30, 2024
$3.34M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$3.44M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$3.88M
May 15, 2025
Q3
2024
Sep 30, 2023
$3.97M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$4.43M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$4.44M
May 10, 2024
Q3
2023
Sep 30, 2022
$5.14M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$5.06M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$4.52M
May 5, 2023
Q3
2022
Sep 30, 2021
$5.10M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$4.77M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$3.89M
May 11, 2022
Q3
2021
Sep 30, 2020
$3.59M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$1.98M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$3.86M
May 11, 2021
Q3
2020
Sep 30, 2019
$4.37M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$4.48M
Aug 7, 2020